For HER2+ Breast Cancer, Anthracyclines and Trastuzumab Are Safer in Sequence For HER2+ Breast Cancer, Anthracyclines and Trastuzumab Are Safer in Sequence

Treating operable HER2-positive breast cancer with anthracyclines and trastuzumab in sequence works as well as giving them together, and it ' s safer, researchers suggest.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news